Centerline Wealth Advisors’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.48M Buy
90,672
+1,905
+2% +$153K 2.34% 15
2026
Q1
$6.72M Sell
88,767
-4,187
-5% -$327K 2.42% 15
2025
Q4
$6.96M Buy
92,954
+264
+0.3% +$19.7K 2.52% 13
2025
Q3
$6.82M Buy
92,690
+49,577
+115% +$3.56M 2.97% 15
2025
Q2
$3.05M Buy
+43,113
New +$2.87M 1.5% 19

Other funds holding JIRE

Centerline Wealth Advisors's JIRE Position: Q2 2026 in Review

Centerline Wealth Advisors increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 2.1% in Q2 2026, buying an estimated $153K and bringing the position to 90,672 shares worth $7.48M. The position accounts for 2.34% of the portfolio, ranked #15.

Centerline Wealth Advisors first reported a position in JIRE in Q2 2025 and has held it in 5 quarters since. 351 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Centerline Wealth Advisors held 90,672 shares of JPMorgan International Research Enhanced Equity ETF worth $7.48M as of Q2 2026.
  • Centerline Wealth Advisors bought 1,905 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $153K.
  • JPMorgan International Research Enhanced Equity ETF made up 2.34% of Centerline Wealth Advisors's portfolio in Q2 2026, its #15 holding.
  • Centerline Wealth Advisors first reported a position in JPMorgan International Research Enhanced Equity ETF in Q2 2025 and has held it in 5 quarters since.
  • 351 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Centerline Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.